Citigroup’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.75M | Sell |
182,049
-23,291
| -11% | -$736K | ﹤0.01% | 1314 |
|
|
2025
Q1 | $6.82M | Buy |
205,340
+5,539
| +3% | +$184K | ﹤0.01% | 1189 |
|
|
2024
Q4 | $6.88M | Buy |
199,801
+21,958
| +12% | +$756K | ﹤0.01% | 1184 |
|
|
2024
Q3 | $7.11M | Buy |
177,843
+15,859
| +10% | +$634K | ﹤0.01% | 1101 |
|
|
2024
Q2 | $4.89M | Sell |
161,984
-1,546
| -0.9% | -$46.6K | ﹤0.01% | 1183 |
|
|
2024
Q1 | $5.49M | Sell |
163,530
-3,489
| -2% | -$117K | ﹤0.01% | 1201 |
|
|
2023
Q4 | $5.39M | Buy |
167,019
+142,537
| +582% | +$4.6M | ﹤0.01% | 1088 |
|
|
2023
Q3 | $802K | Sell |
24,482
-8,167
| -25% | -$268K | ﹤0.01% | 2062 |
|
|
2023
Q2 | $1.15M | Buy |
32,649
+10,703
| +49% | +$377K | ﹤0.01% | 2143 |
|
|
2023
Q1 | $717K | Sell |
21,946
-6,415
| -23% | -$209K | ﹤0.01% | 2263 |
|
|
2022
Q4 | $1.56M | Buy |
28,361
+2,126
| +8% | +$117K | ﹤0.01% | 1694 |
|
|
2022
Q3 | $1.16M | Buy |
26,235
+5,965
| +29% | +$264K | ﹤0.01% | 1997 |
|
|
2022
Q2 | $989K | Sell |
20,270
-4,902
| -19% | -$239K | ﹤0.01% | 2083 |
|
|
2022
Q1 | $1.23M | Buy |
25,172
+4,030
| +19% | +$196K | ﹤0.01% | 2164 |
|
|
2021
Q4 | $901K | Buy |
21,142
+18,211
| +621% | +$776K | ﹤0.01% | 2650 |
|
|
2021
Q3 | $112K | Buy |
2,931
+785
| +37% | +$30K | ﹤0.01% | 3637 |
|
|
2021
Q2 | $61K | Buy |
2,146
+1,251
| +140% | +$35.6K | ﹤0.01% | 4055 |
|
|
2021
Q1 | $30K | Sell |
895
-424
| -32% | -$14.2K | ﹤0.01% | 4341 |
|
|
2020
Q4 | $48K | Buy |
+1,319
| New | +$48K | ﹤0.01% | 4117 |
|